Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Eri, Himeno"'
Autor:
Frank M. LaFerla, Nobutaka Sakae, Takeshi Tabira, Kyoko Iinuma, Eri Himeno, Ryo Yamasaki, Yasumasa Ohyagi, Norimichi Nakamura, Yutaka Kiyohara, Jun Ichi Kira, Kazuhiro Irie, Noriaki Kinoshita, Toru Iwaki, Naoko Soejima, Kazuma Murakami
Publikováno v:
Scopus-Elsevier
Amyloid-β protein (Aβ) accumulates in the neurons of Alzheimer's disease (AD) patients at an early stage of the disease. Recently, we found that Aβ with a toxic turn at positions 22 and 23 accumulates in neurons in AD brain. Here, we studied the a
Autor:
Linqing Ma, Jun Ichi Kira, Katsue Miyoshi, Nobutaka Sakae, Yasumasa Ohyagi, Yuki Yanagihara, Norimichi Nakamura, Eri Himeno, Kyoko Iinuma, Ryo Yamasaki, Naoko Soejima
Publikováno v:
Journal of Alzheimer's Disease. 27:225-237
Apomorphine hydrochloride (APO) is known to be a dopamine receptor agonist, and has recently been found to be a novel drug for Alzheimer's disease (AD). We found that APO treatment ameliorated oxidative stress in an AD mouse model and specifically at
Autor:
Frank M. LaFerla, Nobutaka Sakae, Takeshi Tabira, Yasumasa Ohyagi, Naoko Soejima, Tetsuya Hashimoto, Ryo Yamasaki, Katsue Miyoshi, Kyoko Motomura, Eri Himeno, Norimichi Nakamura, Linqing Ma, Jun Ichi Kira
Publikováno v:
Annals of Neurology. 69:248-256
Objective: Intracellular amyloid b-protein (Ab) contributes to neurodegeneration in Alzheimer disease (AD). Apomorphine (APO) is a dopamine receptor agonist for Parkinson disease and also protects against oxidative stress. Efficacy of APO for an AD m
Publikováno v:
No to shinkei = Brain and nerve. 58(4)
Alexia with agraphia is very rare symptom in multiple sclerosis. We present a patient of opticospinal multiple sclerosis with kanji-predominant alexia with agraphia. A 55-year-old, right-handed man was admitted to our hospital because of difficulty i
Autor:
Eri, Himeno, Hiroyuki, Murai, Hirofumi, Ochi, Masakazu, Kawajiri, Takayuki, Taniwaki, Jun-ichi, Kira
Publikováno v:
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine. 93(5)
Autor:
Yasumasa Ohyagi, Yuji Kawano, J. I. Kira, Hirokazu Shiraishi, Masakatsu Motomura, Hiroyuki Murai, T. Noda, Eri Himeno
Publikováno v:
Neurology. 67:174-174
Approximately 80% of patients with myasthenia gravis (MG) show a high antibody (Ab) titer against acetylcholine receptor (AChR). Patients with MG who do not have high titer of anti-AChR are called seronegative MG (SNMG) and their clinical characteris